These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13454502)

  • 1. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
    DI PIETRO S
    Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)].
    HEILMANN D
    Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Failure of attempted treatment of multiregional lymphosarcomatosis with the new antitumoral quinone E 39].
    MOULINIER J
    J Med Bord; 1957 Jul; 134(7):953-6. PubMed ID: 13449493
    [No Abstract]   [Full Text] [Related]  

  • 4. [Attempted treatment of advanced cancer with a derivative of the ethylene-imine-quinone group (E 39 or 6870 RP)].
    JANBON M; BERTRAND L; BERTRAND A; FLANDRE O
    Montp Med; 1958 Jun; 53(6):863-4. PubMed ID: 13589947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical observations on the use of the compound E 39 in anticellular chemotherapy].
    CONSOLI G; RUSSO N
    Riforma Med; 1957 Jun; 71(22):624-9. PubMed ID: 13454506
    [No Abstract]   [Full Text] [Related]  

  • 6. [SUCCESSFUL RESULT OF THE USE OF CYTOSTATIC DRUGS OF THE ETHYLENEIMINO-BENZOQUINONE GROUP IN THE TREATMENT OF CANCER OF THE UTERINE CERVIX].
    LUCER C; SZLAZAK W
    Pol Tyg Lek; 1965 Jan; 20():70-1. PubMed ID: 14331136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Bayer E 39 in otolaryngology; clinical and histological study].
    BAUER E
    Krebsarzt; 1957 Jun; 12(3):129-50. PubMed ID: 13450291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Critical evaluation of certain results obtained with E-39].
    FARELLO G
    Riforma Med; 1957 Jun; 71(22):630-5. PubMed ID: 13454507
    [No Abstract]   [Full Text] [Related]  

  • 9. [Previous experiences with ethyleneiminobenzo-quinone in the treatment of malignant tumors in experiments and in clinical medicine].
    DOMAGK G
    Arch Int Pharmacodyn Ther; 1962 Dec; 140():688-94. PubMed ID: 14028497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fundamentals & problems of chemotherapy of tumors].
    DOMAGK G
    Riforma Med; 1957 Jun; 71(22):601-3. PubMed ID: 13454500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary report on the use of a new cytotoxic drug in the treatment of tumors].
    ROSA L; GIUNGI F; FRANCO T
    Riforma Med; 1957 Jun; 71(22):619-20. PubMed ID: 13454504
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical results with Bayer E 39].
    HINTERBERGER K; KRETZ J
    Krebsarzt; 1957 Jun; 12(3):157-66. PubMed ID: 13450293
    [No Abstract]   [Full Text] [Related]  

  • 13. [New antineoplastic drugs].
    DE SOCIO V
    Rass Int Clin Ter; 1957 Feb; 37(4):148-54. PubMed ID: 13420462
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolonged oral medication of Bayer E39 (cytostatic)].
    HESSE F; KAMPEN G
    Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
    [No Abstract]   [Full Text] [Related]  

  • 15. [Paradoxical effects of E 39].
    DUCHESNAY G
    Bull Med; 1957 Jan; 71(1):22. PubMed ID: 13413431
    [No Abstract]   [Full Text] [Related]  

  • 16. [First results concerning the effects of the cytostatic drug Bayer E-39].
    VERGA P; PERRONE V
    Riforma Med; 1957 Jun; 71(22):604-7. PubMed ID: 13454501
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of certain benzoquinone-ethyleneimino derivatives on experiemental mouse leukemia].
    SOBESLAVSKY C; SOCHMAN J; MOTYCKA K
    Neoplasma; 1959; 6():268-74. PubMed ID: 13832381
    [No Abstract]   [Full Text] [Related]  

  • 18. [E 39, a new antitumoral substance of the ethyleneimine-qulnone group; properties and clinical indications].
    PESTEL M
    Presse Med (1893); 1956 Sep; 64(64):1474-5. PubMed ID: 13379258
    [No Abstract]   [Full Text] [Related]  

  • 19. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?
    Butler J; Hoey BM
    Br J Cancer Suppl; 1987 Jun; 8():53-9. PubMed ID: 3307874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinone structure-antitumor activity relationships.
    Driscoll JS
    Cancer Chemother Rep 2; 1974 Dec; 4(4):3-4. PubMed ID: 4475612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.